ForeningsSparbanken (Swedbank) second quarter report 2003
STOCKHOLM, Sweden, August 19, 2003 (PRIMEZONE) -- ForeningsSparbanken (Other OTC:FGSKY): Second-Quarter report for 2003 will be published on Friday, August 22, at 7:30AM CET (06:30 GMT).
Innogenetics Reports Results for the First Half of 2003 in Line with Expectations
GENT, Belgium, Aug. 19, 2003 (PRIMEZONE) -- Innogenetics (Other OTC:INGTF) today announced its unaudited results for the first half ending June 30, 2003.
PGS Second Quarter 2003 Earnings Release
OLSO, Norway, Aug. 19, 2003 (PRIMEZONE) -- Petroleum Geo-Services ASA (`PGS`) (OSE:PGS) (Other OTC:PGOGY) will announce its second quarter 2003 financial results at approximately 3:30 p.m. Central European Time (CET) (9:30 a.m. Eastern Time (ET)) today, Tuesday, August 19, 2003.
Jeeves positive development continues
STOCKHOLM, Sweden, August 19, 2003 (PRIMEZONE) -- Jeeves Information Systems AB (publ) (Stockholm:JEEV): Interim Report January- June 2003
Decisions from OM's extraordinary general meeting
STOCKHOLM, Sweden, August 19, 2003 (PRIMEZONE) -- As a consequence of OM AB's (Other OTC:OMGPF) (OM) public offer to the shareholders and warrant holders of the Finnish company, HEX Oyj (HEX), an extraordinary general meeting of the shareholders of OM on August 18 decided to authorize the Board of Directors to decide on the issuance of not more than 31,785,027 shares, entailing an increase in the company's share capital by not more than SEK 63,570,054. The authorization also covers HEX shares, which may be issued as a consequence of the exercise of warrants in HEX.
Anoto Group AM -- Interim Report January - June 2003
LUND, Sweden, August 19, 2003 (PRIMEZONE) Anoto Group AB:
Karo Bio updates status of compound from Merck collaboration
HUDDINGE, Sweden, August 19, 2003 (PRIMEZONE) -- Karo Bio (Other OTC:KARBF) announces today that Merck & Co, Inc. (NYSE:MRK) has decided to discontinue development of the first of the two candidate compounds that have been identified in the collaboration between the two companies. Development of the compound was discontinued due to adverse findings in the final stages of preclinical testing. The second drug candidate continues to be studied in preclinical testing. In addition, other estrogen receptor compounds, arising from the Karo Bio and Merck & Co, Inc. collaboration continue to be evaluated.
Brixton Estate PLC - video interviews with CEO and Deputy CEO
LONDON, United Kingdom, August 19, 2003 (PRIMEZONE) -- Brixton Estate PLC (Other OTC:BXTOF): Interim Results
Anoto Group AB Invites to telephone conference Tuesday 19th of August 2003, 9.30 am
LUND, Sweden, August 19, 2003 (PRIMEZONE) -- Anoto Group AB (Other OTC:AOTOF):
TTPCom to Take Minority Stake in Synergenix Interactive Wireless Gaming Activities to be Merged
CAMBRIDGE, U.K., August 19, 2003 (PRIMEZONE) -- TTP Communications plc (LSE:TTC) ("TTPCom"), the world leading independent supplier of digital wireless communications technology, today announces that its subsidiary, TTPCom Limited, has taken a significant minority stake in Synergenix Interactive AB as part of an agreement that will lead to the convergence of their wireless gaming activities. Synergenix has developed mophun(TM), a wireless gaming platform which features in the Sony Ericsson T300, T310 and T610 mobile phones.
